PURPOSE
thrombocytopenia, MDS
THROMBOCYTOPENIA, MYELODYSPLASTIC SYNDROMES
In myelodysplastic syndromes (MDS), severe thrombocytopenia is associated with poor prognosis. This multicenter trial presents the second-part long-term efficacy and safety results of eltrombopag in patients with low-risk MDS and severe thrombocytopenia.